Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator
1 clinical trials · Condition
◉ Watch Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors (NCT07584499) | Sun Yat-sen University | 2026-05-30 |
Track Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator automatically
Every clearance here is in the API, with alerts when new ones post.